Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

169 public trials 17 recruiting studies

Multiple Sclerosis, Relapsing-Remitting trial results

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • The University of South Alabama Mobile, Alabama, United States
  • St. Joseph's Hospital & Medical Center - Barrow Neurological Institute Phoenix, Arizona, United States
  • CommonSpirit Health Research Institute Carmichael, California, United States
View all 47 locations
Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Mapi Pharma Research site 08 Birmingham, Alabama, United States
  • Mapi Pharma Research site 11 Cullman, Alabama, United States
  • Mapi Pharma Research site 15 Pasadena, California, United States
  • Mapi Pharma Research site 14 Denver, Colorado, United States
View all 112 locations
Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • Oklahoma Medical Research Foundation Oklahoma City, Oklahoma, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States